Sign in

CIK 0001069899 · Large accelerated filer

PHIBRO ANIMAL HEALTH CORP

Sign in to watch
Ticker
PAHC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
131840497
Phone
201-329-7300
Business address
GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
Former names
PHILIPP BROTHERS CHEMICALS INC
  1. 4 Planned sale President and CEO sold 21,120 shares at an average $52.27 ($1,103,938)
  2. 4 Planned sale President and CEO sold 14,080 shares at an average $50.84 ($715,775)
  3. 4 Planned sale President and CEO sold 14,080 shares at an average $51.68 ($727,646)
  4. 4 Planned sale President and CEO sold 72,198 shares at an average $51.77 ($3,737,711)
  5. 4 Other disposition Chief Financial Officer disposed of 12,528 shares (other)
  6. 144 Insider Sale of Securities
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. 4 Planned sale President and CEO sold 110,842 shares at an average $48.38 ($5,362,103)
  9. 4 Planned sale President and CEO sold 13,180 shares at an average $41.39 ($545,473)
  10. 8-K Event Results of operations
  11. 10-Q Report Quarterly Report
  12. 8-K Event Other events
  13. 4 Planned sale President and CEO sold 13,465 shares at an average $40.11 ($540,037)
  14. 4 Planned sale President and CEO sold 1,235 shares at $40.55 ($50,084)
  15. 4 Planned sale President and CEO sold 27,845 shares at an average $41.82 ($1,164,547)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Planned sale President and CEO sold 14,134 shares at an average $40.31 ($569,753)
  18. 4 Planned sale President and CEO sold 213 shares at $40.16 ($8,554)
  19. 4 Planned sale President and CEO sold 328 shares at $40.09 ($13,149)
  20. 8-K Event Executive or director change · Regulation FD disclosure

Page 4 of 39 · 774 filings